Paragon Bioservices – Baltimore, MD
Founded in 1990, Paragon Bioservices is a contract research and manufacturing organization whose focus is the production of reagent-grade proteins and biopharmaceuticals for clinical use. Areas of expertise include: therapeutic proteins, monoclonal antibodies, vaccines, viral vectors and bacteriophage. The cGMP manufacturing space includes microbial and mammalian suites, fill-finish, and fully-segregated virus/BSL-3 facilities. Paragon is a preferred vendor for many of the leading global pharmaceutical companies and currently has multiple ongoing contracts for the US government.
Avid Radiopharmaceuticals – Philadelphia, PA
Avid Radiopharmaceuticals, a wholly owned subsidiary of drug giant Eli Lilly & Co., is receiving worldwide attention now that an advisory committee for the U.S. Food and Drug Administration (FDA) has recommended conditional approval for Avid’s lead asset Amyvid.
ipConfigure, Inc. – Norfolk, VA
ipConfigure, Inc. is a privately owned research and development software company. As a leading developer of enterprise IP video surveillance solutions, ipConfigure offers a variety of products – all of which leverage a browser-based interface and are capable of seamlessly supporting unlimited cameras, locations and users.
NewLeaf Symbiotics – St. Louis, MO
For years, conventional wisdom held that Pink Pigmented Facultative Methylotrophs (PPFMs) contaminated plants. It turns out conventional wisdom was wrong. In 1995 biologist/professor Mark Holland discovered that PPFMs actually produce a host of unexpected and important benefits for plants, and “eat” plant waste products. His “eureka” findings led to several patents and to the creation of NewLeaf Symbiotics (NLS). NewLeaf Symbiotics was formed in 2012 to develop and commercialize one of the most prevalent, beneficial bacteria found in nature. NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria.